References
- Martínez-Martínez MU, Oostdam DAH, Abud-Mendoza C. Diffuse Alveolar Hemorrhage in Autoimmune Diseases. Curr Rheumatol Rep. 2017;19(5):27.
- Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137(5):1164-1171.
- Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis. 2002;39(1):42-47.
- Alexandre AT, Vale A, Gomes T. Diffuse alveolar hemorrhage: how relevant is etiology?. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):47-52.
- Levi M, van Der POLL T, ten CATE H, et al. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees. Am J Respir Crit Care Med. 1998;158(1):92-98.
- Heslet L, Nielsen JD, Levi M, Sengeløv H, Johansson PI. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care. 2006;10(6):177.
- Marti-Carvajal AJ, Salanti G, Marti-Carvajal PI. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev. 2007;(1):CD004887.
- Hedner U. Recombinant activated factor VII: 30 years of research and innovation. Blood Rev. 2015;29 Suppl 1:S4-S8.